文献速递临床微生物分子诊断

LIAISON PLEX 革兰阴性血培养检测的性能评估

Performance of the LIAISON PLEX gram-negative blood culture assay for identifying bacterial pathogens and resistance genes in blood cultures.
PubMed 文献 · J Clin Microbiol · 2026-05-22

多中心研究评估自动化多重 LIAISON PLEX 革兰阴性血培养检测(BCN)在阳性血培养中鉴定 19 种革兰阴性菌和 8 种耐药基因的性能,约 2 小时出结果。前瞻加预选标本中,18/19 菌种敏感性 90.0%-100%,耐药基因 97.8%-100%,特异性均≥99.3%。结论为该检测敏感性和特异性优异,可快速鉴定病原及耐药基因。

要点

  • LIAISON PLEX BCN 检测约 2 小时可鉴定 19 种革兰阴性菌和 8 种耐药基因。
  • 前瞻加预选标本中 18/19 菌种敏感性 90.0%-100%,耐药基因 97.8%-100%。
  • 所有 19 个菌种特异性≥99.3%,耐药基因特异性≥99.6%。

核心结论

  • LIAISON PLEX BCN 检测对阳性血培养中革兰阴性菌及耐药基因具有优异的敏感性和特异性,可快速鉴定病原。

研究设计与样本

  • 多中心研究评估自动化多重 LIAISON PLEX 革兰阴性血培养检测,标本包括 351 份前瞻收集、231 份预选和 746 份模拟标本。

主要发现

  • 前瞻加预选标本中,18/19 个菌种靶标敏感性/阳性符合率为 90.0%-100%,检测到的耐药基因阳性符合率为 97.8%-100%。
  • 所有 19 个菌种靶标特异性/阴性符合率≥99.3%,耐药基因特异性≥99.6%。
  • 前瞻标本常见病原为大肠埃希菌(51.4%)、肺炎克雷伯菌(12.9%)和假单胞菌属(8.3%)。
  • 模拟标本所有靶标敏感性和特异性平均均>99.8%,13 种测试瓶/基质类型对 21 个可检测病原均 100% 检出。
  • 检测累计鉴定 246 株可报告在目标内的菌株,显示广泛包容性;41 株非面板革兰阴性菌中 17 株有交叉反应,61 株革兰阳性菌和 11 株真菌无交叉反应。

临床怎么用

  • 该检测可在阳性血培养中快速鉴定革兰阴性菌及耐药基因,有助于尽早启动优化抗菌治疗。

局限性

  • 研究包含模拟标本,可能不完全反映临床标本的真实性能;部分非面板革兰阴性菌存在交叉反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gram-negative bacteria cause potentially life-threatening bloodstream infections worldwide. Delayed initiation of optimal antimicrobial therapy worsens health outcomes. Molecular assays characterize bloodstream pathogens and their antimicrobial resistance (AMR) genes faster than gold-standard culture-based methods. This multi-site study evaluated the performance of the automated multiplex LIAISON PLEX Gram-Negative Blood Culture (BCN) Assay (Luminex Corporation), which tests positive blood cultures for 19 gram-negative bacteria and 8 AMR genes, in approximately 2 h. Samples included 351 prospectively collected, 231 pre-selected, and 746 contrived specimens. For combined prospective plus pre-selected specimens, sensitivity/positive percent agreement was 90.0%-100% for 18/19 on-panel bacterial targets, and 97.8%-100% for detected AMRs. Specificity/negative percent agreement was ≥99.3% for all 19 bacterial targets, and ≥99.6% for AMRs. Common pathogens in prospective samples were Escherichia coli (51.4%), Klebsiella pneumoniae (12.9%), and Pseudomonas spp. (8.3%). Contrived specimen sensitivity and specificity both averaged >99.8% across all assay targets. All 13 tested bottle/matrix types gave 100% detection of 21 targetable pathogens tested. The assay identified a cumulative 246 reportable on-target strains, indicating broad inclusivity. Cross-reactivity was observed with 17/41 off-panel gram-negative bacteria; no cross-reactivity was observed with 61 gram-positive bacteria or 11 fungal pathogens. Low concentrations of 10 on-panel bacteria were detectable alongside high concentrations of 9 other on-panel targets or 7 gram-positive potential confounders. Six potential interfering substances in blood culture bottles had no impact on the detection of four representative on-target bacteria. Reproducibility approached 100% both within-lab and across sites. The LIAISON PLEX BCN Assay provides excellent sensitivity and specificity for quickly characterizing gram-negative bacterial pathogens and their resistance genes in positive blood culture specimens.IMPORTANCEBloodstream bacterial infections may cause serious illness and death. Successful treatment demands rapid pathogen identification so the optimal antibiotic therapy can be initiated. Blood culture is standard for confirming bloodstream infection but may not provide detailed pathogen information in a timely manner. The LIAISON PLEX Gram-Negative Blood Culture assay quickly analyzes blood cultures to identify 19 pathogenic gram-negative bacteria and 8 associated antibiotic drug resistance genes. The LIAISON PLEX BCN Assay demonstrated a high degree of reliability in rapidly characterizing the infective pathogen and associated resistance genes in blood cultures from 582 patients with demonstrated gram-negative bloodstream infection. Assay performance was confirmed in 746 contrived samples in which samples were spiked with different gram-negative bacteria.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Dhiman N, Emery CL, Chow S-K, et al. Performance of the LIAISON PLEX gram-negative blood culture assay for identifying bacterial pathogens and resistance genes in blood cultures. J Clin Microbiol. 2026. PMID: 42171454. doi:10.1128/jcm.00018-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。